Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
Top Cited Papers
Open Access
- 1 September 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 163 (3), 1101-1107
- https://doi.org/10.1016/s0002-9440(10)63469-4
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Mutation and overexpression of the β-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese peopleZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Frequent β-catenin aberration in human hepatocellular carcinomaHepatology Research, 2001
- Expression of mRNA for DNA methyltransferases and methyl-CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesisHepatology, 2001
- Axin and hepatocellular carcinomasNature Genetics, 2000
- Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosityOncogene, 1999
- Increasing evidence that hepatitis B virus X gene protein and p53 protein may interact in the pathogenesis of hepatocellular carcinomaHepatology, 1997
- p53 Abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exonsCarcinogenesis: Integrative Cancer Research, 1996
- p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from thailandInternational Journal of Cancer, 1993
- Analysis of the P53 Tumor–Suppressor Gene in Hepatocellular Carcinomas From BritainHepatology, 1992
- Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern AfricaNature, 1991